Free Trial

Deutsche Bank AG Grows Stock Holdings in Trupanion, Inc. (NASDAQ:TRUP)

Trupanion logo with Finance background

Deutsche Bank AG lifted its position in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 119.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 134,546 shares of the financial services provider's stock after acquiring an additional 73,227 shares during the quarter. Deutsche Bank AG owned 0.32% of Trupanion worth $6,485,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the business. Balyasny Asset Management L.P. grew its stake in Trupanion by 368.2% in the 4th quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider's stock valued at $40,548,000 after acquiring an additional 661,559 shares during the period. Bayesian Capital Management LP purchased a new position in shares of Trupanion during the 4th quarter worth $201,000. BNP Paribas Financial Markets raised its holdings in shares of Trupanion by 170.7% during the 4th quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider's stock worth $16,248,000 after acquiring an additional 212,545 shares during the period. Algert Global LLC purchased a new position in shares of Trupanion during the 4th quarter worth $637,000. Finally, Freestone Grove Partners LP purchased a new stake in Trupanion in the 4th quarter valued at about $7,776,000.

Insider Activity

In related news, SVP Emily Dreyer sold 14,025 shares of the stock in a transaction on Friday, March 7th. The stock was sold at an average price of $32.41, for a total transaction of $454,550.25. Following the completion of the sale, the senior vice president now directly owns 27,645 shares of the company's stock, valued at $895,974.45. This trade represents a 33.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Fawwad Qureshi sold 1,373 shares of the stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $34.22, for a total value of $46,984.06. Following the sale, the chief financial officer now directly owns 2,416 shares of the company's stock, valued at approximately $82,675.52. This represents a 36.24% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 33,792 shares of company stock valued at $1,122,802. 5.42% of the stock is currently owned by company insiders.

Trupanion Stock Down 1.8%

Shares of Trupanion stock traded down $0.85 during trading on Tuesday, hitting $45.30. 352,040 shares of the stock were exchanged, compared to its average volume of 610,943. The stock has a market cap of $1.94 billion, a price-to-earnings ratio of -196.96, a price-to-earnings-growth ratio of 6.02 and a beta of 1.72. The firm's 50-day moving average price is $38.21 and its 200 day moving average price is $44.13. Trupanion, Inc. has a 12-month low of $25.90 and a 12-month high of $57.90. The company has a debt-to-equity ratio of 0.39, a current ratio of 1.71 and a quick ratio of 1.66.

Trupanion (NASDAQ:TRUP - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.05) by $0.02. The firm had revenue of $341.98 million during the quarter, compared to the consensus estimate of $337.81 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. The firm's quarterly revenue was up 11.7% compared to the same quarter last year. During the same period in the prior year, the company posted ($0.16) earnings per share. As a group, analysts forecast that Trupanion, Inc. will post 0.13 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on TRUP. Stifel Nicolaus cut their price target on shares of Trupanion from $44.00 to $41.00 and set a "hold" rating on the stock in a research note on Thursday, February 20th. Lake Street Capital cut their price target on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating on the stock in a research note on Friday, May 2nd. Finally, Piper Sandler cut their price target on shares of Trupanion from $57.00 to $52.00 and set an "overweight" rating on the stock in a research note on Thursday, February 20th. Two analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $51.80.

View Our Latest Stock Report on TRUP

Trupanion Company Profile

(Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Featured Articles

Institutional Ownership by Quarter for Trupanion (NASDAQ:TRUP)

Should You Invest $1,000 in Trupanion Right Now?

Before you consider Trupanion, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.

While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines